These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 30910388

  • 1. Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation.
    Machino-Ohtsuka T, Seo Y, Ishizu T, Yamamoto M, Hamada-Harimura Y, Machino T, Yamasaki H, Sekiguchi Y, Nogami A, Aonuma K, Ieda M.
    J Cardiol; 2019 Sep; 74(3):235-244. PubMed ID: 30910388
    [Abstract] [Full Text] [Related]

  • 2. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U, Dahlström U, Fu M, Lund LH.
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [Abstract] [Full Text] [Related]

  • 3. Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction.
    Sartipy U, Savarese G, Dahlström U, Fu M, Lund LH.
    Eur J Heart Fail; 2019 Apr; 21(4):471-479. PubMed ID: 30698317
    [Abstract] [Full Text] [Related]

  • 4. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T, Seo Y, Ishizu T, Sugano A, Atsumi A, Yamamoto M, Kawamura R, Machino T, Kuroki K, Yamasaki H, Igarashi M, Sekiguchi Y, Aonuma K.
    J Am Coll Cardiol; 2013 Nov 12; 62(20):1857-65. PubMed ID: 23916940
    [Abstract] [Full Text] [Related]

  • 5. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E, Ren X, Steinberg BA, Green CL, Barnett AS, Rosa NS, Al-Khatib SM, Atwater BD, Daubert JP, Frazier-Mills C, Grant AO, Hegland DD, Jackson KP, Jackson LR, Koontz JI, Lewis RK, Sun AY, Thomas KL, Bahnson TD, Piccini JP.
    Heart Rhythm; 2018 May 12; 15(5):651-657. PubMed ID: 29222043
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction.
    Fukui A, Tanino T, Yamaguchi T, Hirota K, Saito S, Okada N, Akioka H, Shinohara T, Yufu K, Takahashi N.
    J Cardiovasc Electrophysiol; 2020 Mar 12; 31(3):682-688. PubMed ID: 31985099
    [Abstract] [Full Text] [Related]

  • 8. A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: The RAFT-AF trial rationale and design.
    Parkash R, Wells G, Rouleau J, Talajic M, Essebag V, Skanes A, Wilton SB, Verma A, Healey JS, Tang AS.
    Am Heart J; 2021 Apr 12; 234():90-100. PubMed ID: 33472052
    [Abstract] [Full Text] [Related]

  • 9. Prognosis and treatment strategies for atrial fibrillation in heart failure with mildly reduced ejection fraction.
    Schupp T, Schmitt A, Reinhardt M, Abel N, Lau F, Abumayyaleh M, Dudda J, Weidner K, Ayoub M, Akin M, Müller J, Akin I, Behnes M.
    Eur J Prev Cardiol; 2024 Aug 22; 31(11):1372-1384. PubMed ID: 38825871
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK, Park JJ, Lim NK, Kim WH, Choi DJ.
    Heart; 2020 Aug 22; 106(15):1160-1168. PubMed ID: 32341140
    [Abstract] [Full Text] [Related]

  • 12. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
    Kroshian G, Joseph J, Kinlay S, Peralta AO, Hoffmeister PS, Singh JP, Yuyun MF.
    J Cardiovasc Electrophysiol; 2024 Apr 22; 35(4):715-726. PubMed ID: 38348517
    [Abstract] [Full Text] [Related]

  • 13. Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community-based study.
    Zhang P, Chamberlain AM, Hodge DO, Cai C, Xiao PL, Han J, Jiang CY, Redfield MM, Roger VL, Cha YM.
    J Cardiovasc Electrophysiol; 2020 Sep 22; 31(9):2275-2283. PubMed ID: 32584498
    [Abstract] [Full Text] [Related]

  • 14. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
    Zafrir B, Lund LH, Laroche C, Ruschitzka F, Crespo-Leiro MG, Coats AJS, Anker SD, Filippatos G, Seferovic PM, Maggioni AP, De Mora Martin M, Polonski L, Silva-Cardoso J, Amir O, ESC-HFA HF Long-Term Registry Investigators.
    Eur Heart J; 2018 Dec 21; 39(48):4277-4284. PubMed ID: 30325423
    [Abstract] [Full Text] [Related]

  • 15. Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction.
    Kanagala P, Arnold JR, Singh A, Khan JN, Gulsin GS, Gupta P, Squire IB, Ng LL, McCann GP.
    Int J Cardiovasc Imaging; 2020 May 21; 36(5):921-928. PubMed ID: 32030576
    [Abstract] [Full Text] [Related]

  • 16. Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas Trial.
    Saksena S, Slee A, Natale A, Lakkireddy DR, Shah D, Di Biase L, Lewalter T, Nagarakanti R, Santangeli P.
    Europace; 2023 May 19; 25(5):. PubMed ID: 37078691
    [Abstract] [Full Text] [Related]

  • 17. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status　- Report From the Japanese Nationwide Multicenter Registry.
    Temma T, Nagai T, Watanabe M, Kamada R, Takahashi Y, Hagiwara H, Koya T, Nakao M, Omote K, Kamiya K, Iwano H, Yamamoto K, Yoshikawa T, Saito Y, Anzai T.
    Circ J; 2020 Feb 25; 84(3):397-403. PubMed ID: 32009066
    [Abstract] [Full Text] [Related]

  • 18. Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction.
    Xie Z, Qi B, Wang Z, Li F, Chen C, Li C, Yuan S, Yao S, Zhou J, Ge J.
    Europace; 2023 Dec 28; 26(1):. PubMed ID: 38099508
    [Abstract] [Full Text] [Related]

  • 19. Comparison of His-Purkinje Conduction System Pacing with Atrial-Ventricular Node Ablation and Pharmacotherapy in HFpEF Patients with Recurrent Persistent Atrial Fibrillation (HPP-AF study).
    Zhang JF, Pan YW, Li J, Kong XG, Wang M, Xue ZM, Gao J, Fu GS.
    Cardiovasc Drugs Ther; 2024 Aug 28; 38(4):847-858. PubMed ID: 36749453
    [Abstract] [Full Text] [Related]

  • 20. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study.
    Zakeri R, Chamberlain AM, Roger VL, Redfield MM.
    Circulation; 2013 Sep 03; 128(10):1085-93. PubMed ID: 23908348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.